CD46 on glial cells can function as a receptor for viral glycoprotein-mediated cell-cell fusion

GLIA

Volumn 52, Issue 3, 2005, Pages 252-258

  Cassiani Ingoni, Riccardo ^a,c   Greenstone, Heather L ^b   Donati, Donatella ^a   Fogdell Hahn, Anna ^a   Martinelli, Elena ^a   Refai, Daniel ^a   Martin, Roland ^a   Berger, Edward A ^b   Jacobson, Steven ^a,d  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Cell fusion; HHV 6; MCP; Multiple sclerosis; MV; Oligodendrocyte

Indexed keywords

GLYCOPROTEIN; MEMBRANE COFACTOR PROTEIN; VIRUS PROTEIN;

ARTICLE; ASTROCYTE; CELL FUSION; CELL TYPE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; GLIA CELL; HERPES; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 6; HUMAN TISSUE; MEASLES VIRUS; MULTIPLE SCLEROSIS; NERVOUS SYSTEM; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; T LYMPHOCYTE; VIRUS INFECTION;

ANIMALS; ANTIGENS, CD46; ASTROCYTES; BRAIN; CAPSID PROTEINS; CENTRAL NERVOUS SYSTEM VIRAL DISEASES; HERPESVIRUS 6, HUMAN; HUMANS; MEMBRANE FUSION; MEMBRANE GLYCOPROTEINS; MEMBRANE PROTEINS; MICE; NEUROGLIA; NIH 3T3 CELLS; OLIGODENDROGLIA; T-LYMPHOCYTES;

EID: 30444454956     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.20219     Document Type: Article

References (40)

1. Albright AV, Lavi E, Black JB, Goldberg S, O'Connor MJ, Gonzalez-Scarano F. 1998. The effect of human herpesvirus-6 (HHV-6) on cultured human neural cells: oligodendrocytes and microglia. J Neurovirol 4:486-494.
2. Alkhatib G, Broder CC, Berger EA. 1996. Cell type-specific fusion cofactors determine human immunodeficiency virus type 1 tropism for T-cell lines versus primary macrophages. J Virol 70:5487-5494.
3. Allen IV, McQuaid S, McMahon J, Kirk J, McConnell R. 1996. The significance of measles virus antigen and genome distribution in the CNS in SSPE for mechanisms of viral spread and demyelination. J Neuropathol Exp Neurol 55:471-480.
4. Alvarez-Dolado M, Pardal R, Garcia-Verdugo JM, Fike JR, Lee HO, Pfeffer K, Lois C, Morrison SJ, Alvarez-Buylla A. 2003. Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes. Nature 425:968-973.
5. Alvarez-Lafuente R, De las Heras V, Bartolome M, Picazo JJ, Arroyo R. 2004. Relapsing-remitting multiple sclerosis and human herpesvirus 6 active infection. Arch Neurol 61:1523-1527.
6. Berti R, Brennan MB, Soldan SS, Ohayon JM, Casareto L, McFarland HF, Jacobson S. 2002. Increased detection of serum HHV-6 DNA sequences during multiple sclerosis (MS) exacerbations and correlation with parameters of MS disease progression. J Neurovirol 8:250-256.
7. Buckland R, Wild TF. 1997. Is CD46 the cellular receptor for measles virus? Virus Res 48:1-9.
8. Buntinx M, Vanderlocht J, Hellings N, Vandenabeele F, Lambrichts I, Raus J, Ameloot M, Stinissen P, Steels P. 2003. Characterization of three human oligodendroglial cell lines as a model to study oligodendrocyte injury: morphology and oligodendrocyte-specific gene expression. J Neurocytol 32:25-38.
9. Cattaneo R. 2004. Four viruses, two bacteria, and one receptor: membrane cofactor protein (CD46) as pathogens' magnet. J Virol 78:4385-4388.
10. Cermelli C, Berti R, Soldan SS, Mayne M, D'Ambrosia JM, Ludwin SK, Jacobson S. 2003. High frequency of human herpesvirus 6 DNA in multiple sclerosis plaques isolated by laser microdissection. J Infect Dis 187:1377-1387.
11. Chakrabarti S, Sisler JR, Moss B. 1997. Compact, synthetic, vaccinia virus early/late promoter for protein expression. Biotechniques 23:1094-1097.
12. Cho SW, Oglesby TJ, Hsi BL, Adams EM, Atkinson JP. 1991. Characterization of three monoclonal antibodies to membrane co-factor protein (MCP) of the complement system and quantification of MCP by radioassay. Clin Exp Immunol 83:257-261.
13. Donati D, Akhyani N, Fogdell-Hahn A, Cermelli C, Cassiani-Ingoni R, Vortmeyer A, Heiss JD, Cogen P, Gaillard WD, Sato S, Theodore WH, Jacobson S. 2003. Detection of human herpesvirus-6 in mesial temporal lobe epilepsy surgical brain resections. Neurology 61:1405-1411.
14. Donati D, Martinelli E, Cassiani-Ingoni R, Ahlqvist J, Hou J, Major EO, Jacobson S. 2005. Variant specific tropism of HHV-6 in human astrocytes. J Virol in pess.
15. Fuerst TR, Niles EG, Studier FW, Moss B. 1986. Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. Proc Natl Acad Sci USA 83:8122-8126.
16. Goodman AD, Mock DJ, Powers JM, Baker JV, Blumberg BM. 2003. Human herpesvirus 6 genome and antigen in acute multiple sclerosis lesions. J Infect Dis 187:1365-1376.
17. Greenstone HL, Santoro F, Lusso P, Berger EA. 2002. Human herpesvirus 6 and measles virus employ distinct CD46 domains for receptor function. J Biol Chem 277:39112-39118.
18. Kim JS, Lee KS, Park JH, Kim MY, Shin WS. 2000. Detection of human herpesvirus 6 variant A in peripheral blood mononuclear cells from multiple sclerosis patients. Eur Neurol 43:170-173.
19. Koski CL, Estep AE, Sawant-Mane S, Shin ML, Highbarger L, Hansch GM. 1996. Complement regulatory molecules on human myelin and glial cells: differential expression affects the deposition of activated complement proteins. J Neurochem 66:303-312.
20. Kurihara H, Zama A, Tamura M, Takeda J, Sasaki T, Takeuchi T. 2000. Glioma/glioblastoma-specific adenoviral gene expression using the nestin gene regulator. Gene Ther 7:686-693.
21. Manchester M, Gairin JE, Patterson JB, Alvarez J, Liszewski MK, Eto DS, Atkinson JP, Oldstone MB. 1997. Measles virus recognizes its receptor, CD46, via two distinct binding domains within SCR1-2. Virology 233:174-184.
22. McQuaid S, Cosby SL. 2002. An immunohistochemical study of the distribution of the measles virus receptors, CD46 and SLAM, in normal human tissues and subacute sclerosing panencephalitis. Lab Invest 82:403-409.
23. Mori Y, Seya T, Huang HL, Akkapaiboon P, Dhepakson P, Yamanishi K. 2002. Human herpesvirus 6 variant A but not variant B induces fusion from without in a variety of human cells through a human herpesvirus 6 entry receptor, CD46. J Virol 76:6750-6761.
24. Mori Y, Yang X, Akkapaiboon P, Okuno T, Yamanishi K. 2003. Human herpesvirus 6 variant A glycoprotein H-glycoprotein L-glycoprotein Q complex associates with human CD46. J Virol 77:4992-4999.
25. Nussbaum O, Broder CC, Berger EA. 1994. Fusogenic mechanisms of enveloped-virus glycoproteins analyzed by a novel recombinant vaccinia virus-based assay quantitating cell fusion-dependent reporter gene activation. J Virol 68:5411-5422.
26. Nussbaum O, Broder CC, Moss B, Stern LB, Rozenblatt S, Berger EA. 1995. Functional and structural interactions between measles virus hemagglutinin and CD46. J Virol 69:3341-3349.
27. Ogata A, Czub S, Ogata S, Cosby SL, McQuaid S, Budka H, ter Meulen V, Schneider-Schaulies J. 1997. Absence of measles virus receptor (CD46) in lesions of subacute sclerosing panencephalitis brains. Acta Neuropathol (Berl) 94:444-449.
28. Plumb J, Duprex WP, Cameron CH, Richter-Landsberg C, Talbot P, McQuaid S. 2002. Infection of human oligodendroglioma cells by a recombinant measles virus expressing enhanced green fluorescent protein. J Neurovirol 8:24-34.
29. Ransohoff RM, Kivisakk P, Kidd G. 2003. Three or more routes for leukocyte migration into the central nervous system. Nat Rev Immunol 3:569-581.
30. Santoro F, Kennedy PE, Locatelli G, Malnati MS, Berger EA, Lusso P. 1999. CD46 is a cellular receptor for human herpesvirus 6. Cell 99:817-827.
31. Schneider-Schaulies J, Schnorr JJ, Brinckmann U, Dunster LM, Baczko K, Liebert UG, Schneider-Schaulies S, ter Meulen V. 1995. Receptor usage and differential downregulation of CD46 by measles virus wild-type and vaccine strains. Proc Natl Acad Sci USA 92:3943-3947.
32. Scolding NJ, Morgan BP, Compston DA. 1998. The expression of complement regulatory proteins by adult human oligodendrocytes. J Neuroimmunol 84:69-75.
33. Seya T, Hirano A, Matsumoto M, Nomura M, Ueda S. 1999. Human membrane cofactor protein (MCP, CD46): multiple isoforms and functions. Int J Biochem Cell Biol 31:1255-1260.
34. Seya T, Kurita M, Hara T, Iwata K, Semba T, Hatanaka M, Matsumoto M, Yanagi Y, Ueda S, Nagasawa S. 1995. Blocking measles virus infection with a recombinant soluble form of, or monoclonal antibodies against, membrane cofactor protein of complement (CD46). Immunology 84:619-625.
35. Seya T, Kurita M, Iwata K, Yanagi Y, Tanaka K, Shida K, Hatanaka M, Matsumoto M, Jun S, Hirano A, Ueda S, Nagasawa S. 1997. The CD46 transmembrane domain is required for efficient formation of measles-virus-mediated syncytium. Biochem J 322 (Pt 1):135-144.
36. Shusta EV, Zhu C, Boado RJ, Pardridge WM. 2002. Subtractive expression cloning reveals high expression of CD46 at the blood-brain barrier. J Neuropathol Exp Neurol 61:597-604.
37. Singhrao SK, Neal JW, Rushmere NK, Morgan BP, Gasque P. 2000. Spontaneous classical pathway activation and deficiency of membrane regulators render human neurons susceptible to complement lysis. Am J Pathol 157:905-918.
38. Soldan SS, Fogdell-Hahn A, Brennan MB, Mittleman BB, Ballerini C, Massacesi L, Seya T, McFarland HF, Jacobson S. 2001. Elevated serum and cerebrospinal fluid levels of soluble human herpesvirus type 6 cellular receptor, membrane cofactor protein, in patients with multiple sclerosis. Ann Neurol 50:486-493.
39. van Dixhoorn MG, Dekker S, Janssen RW, Verbakel CA, Grosveld F. 2000. Human CD46 rather than CD55 is a key element in protection against complement activation in vitro. Transplant Proc 32:916-918.
40. Weimann JM, Charlton CA, Brazelton TR, Hackman RC, Blau HM. 2003. Contribution of transplanted bone marrow cells to Purkinje neurons in human adult brains. Proc Natl Acad Sci USA 100:2088-2093.